Pharmaceutical Industry in India: Market Research Reports, Statistics and Analysis

You might be interested in: drug, clinical trial, vaccine, more »

» Download Public Reports

About 1 700 reports
Biocon Ltd. - Company Report for Year 2013

Biocon Ltd. - Company Report for Year 2013

  • Company report
  • April 2013
  • 15 pages
  • by Corporation

... Decreased from ~50% of the overall statin market to ~40% this year while the atorvastatin market has grown. It is because generic atorvastatin is taking the market share away from the innovator brand ...

Biocon Ltd. - Company Report For Year 2013

April 2013

Company Report: Generic Drug In India For Year 2013

April 2013

The Indian Medicine Sector

April 2013

Drug In India : Innovation And Technology Trends

April 2013

» Purchase Premium Reports (From $ 125 - $ 6 995)

About 600 reports
Evista (Osteoporosis) - Forecast and Market Analysis to 2022

Evista (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Evista (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Evista (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

Reclast (osteoporosis) - Forecast And Market Analysis T ...

February 2013 $ 6 995

Forteo (osteoporosis) - Forecast And Market Analysis To ...

February 2013 $ 6 995

Protelos (osteoporosis) - Forecast And Market Analysis ...

February 2013 $ 6 995

Pharmapoint: Osteoporosis - India Drug Forecast And Mar ...

February 2013 $ 4 995

Pharmapoint: Multiple Sclerosis - India Drug Forecast A ...

March 2013 $ 4 995

Vaccines - Top 10 Global Markets Package

May 2013 $ 5 174

» Read our Company Profiles

26 Companies

GlaxoSmithKline P.L.C.

United States

Cipla Ltd.

India

GlaxoSmithKline PLC

United Kingdom

Abbott Laboratories

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.